Proactive, short-term PCSK9 inhibition after PCI in patients with coronary artery disease at high residual risk: rationale and design of the randomized HANYANG-PICK trial

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-03-02
DOI
https://doi.org/10.3389/fcvm.2026.1761093
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Proactive, short-term PCSK9 inhibition after PCI in patients with coronary artery disease at high residual risk: rationale and design of the randomized HANYANG-PICK trial

Soojung Park, Hyungdon Kook, Woohyeun Kim, Young-Hyo Lim et al.
Frontiers in Cardiovascular Medicine
Lipoproteins and Cardiovascular Health
article

Proactive, short-term PCSK9 inhibition after PCI in patients with coronary artery disease at high residual risk: rationale and design of the randomized HANYANG-PICK trial

Soojung Park, Hyungdon Kook, Woohyeun Kim, Young-Hyo Lim, Jeong-Hun Shin
article en

Abstract

No abstract available for this paper.
Frontiers in Cardiovascular MedicineVol. 13
Hanyang University Guri Hospital (KR), Hanyang University Seoul Hospital (KR), Hanyang University (KR)
Good health and well-being
Openalex Percentile: Top 36%
Lipoproteins and Cardiovascular Health
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.